BIOMAT Database Logo BIOMAT Database Logo

Utility and safety of Hickman catheters for venous access after bone marrow transplantation. 1998

T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
First Department of Internal Medicine, Tokyo Medical and Dental University.

Hickman catheters are useful for vascular access after bone marrow transportation because they can handle large volume and allow for easy transfusions and blood drawing through wide double lumens making it easier to case for patients under sterile conditions in a clean room. However, the safety of Hickman catheters as compared to Silastic catheters in marrow transplants has never been discussed. We therefore retrospectively reviewed the complications of two catheters in 71 allogeneic bone marrow transplant recipients between September 1986 and August 1994. The complication and infection rates of Hickman catheters were 0.21 and 0.09 per 100 device-life days, and rate of temperature >38 degrees C during leukocytopenia (<1,000 white blood cells) was 0.18. These rates were not different from those of Silastic catheters suggesting that Hickman catheters are safe and acceptable in marrow transplantation. The benefits and drawbacks of Hickman catheters relevant to catheter choice were also discussed.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008228 Lymphoma, Non-Hodgkin Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. Non-Hodgkin Lymphoma,Diffuse Mixed Small and Large Cell Lymphoma,Diffuse Mixed-Cell Lymphoma,Diffuse Small Cleaved-Cell Lymphoma,Diffuse Undifferentiated Lymphoma,Lymphatic Sarcoma,Lymphoma, Atypical Diffuse Small Lymphoid,Lymphoma, Diffuse,Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic,Lymphoma, High-Grade,Lymphoma, Intermediate-Grade,Lymphoma, Low-Grade,Lymphoma, Mixed,Lymphoma, Mixed Cell, Diffuse,Lymphoma, Mixed Lymphocytic-Histiocytic,Lymphoma, Mixed Small and Large Cell, Diffuse,Lymphoma, Mixed-Cell,Lymphoma, Mixed-Cell, Diffuse,Lymphoma, Non-Hodgkin's,Lymphoma, Non-Hodgkin, Familial,Lymphoma, Non-Hodgkins,Lymphoma, Nonhodgkin's,Lymphoma, Nonhodgkins,Lymphoma, Pleomorphic,Lymphoma, Small Cleaved Cell, Diffuse,Lymphoma, Small Cleaved-Cell, Diffuse,Lymphoma, Small Non-Cleaved-Cell,Lymphoma, Small Noncleaved-Cell,Lymphoma, Small and Large Cleaved-Cell, Diffuse,Lymphoma, Undifferentiated,Lymphoma, Undifferentiated, Diffuse,Lymphosarcoma,Mixed Small and Large Cell Lymphoma, Diffuse,Mixed-Cell Lymphoma,Mixed-Cell Lymphoma, Diffuse,Non-Hodgkin's Lymphoma,Reticulosarcoma,Reticulum Cell Sarcoma,Reticulum-Cell Sarcoma,Sarcoma, Lymphatic,Sarcoma, Reticulum-Cell,Small Cleaved-Cell Lymphoma, Diffuse,Small Non-Cleaved-Cell Lymphoma,Small Noncleaved-Cell Lymphoma,Undifferentiated Lymphoma,Diffuse Lymphoma,Diffuse Lymphomas,Diffuse Mixed Cell Lymphoma,Diffuse Mixed-Cell Lymphomas,Diffuse Small Cleaved Cell Lymphoma,Diffuse Undifferentiated Lymphomas,High-Grade Lymphoma,High-Grade Lymphomas,Intermediate-Grade Lymphoma,Intermediate-Grade Lymphomas,Low-Grade Lymphoma,Low-Grade Lymphomas,Lymphatic Sarcomas,Lymphocytic-Histiocytic Lymphoma, Mixed,Lymphocytic-Histiocytic Lymphomas, Mixed,Lymphoma, Diffuse Mixed-Cell,Lymphoma, Diffuse Undifferentiated,Lymphoma, High Grade,Lymphoma, Intermediate Grade,Lymphoma, Low Grade,Lymphoma, Mixed Cell,Lymphoma, Mixed Lymphocytic Histiocytic,Lymphoma, Non Hodgkin,Lymphoma, Non Hodgkin's,Lymphoma, Non Hodgkins,Lymphoma, Nonhodgkin,Lymphoma, Small Non Cleaved Cell,Lymphoma, Small Noncleaved Cell,Lymphosarcomas,Mixed Cell Lymphoma,Mixed Cell Lymphoma, Diffuse,Mixed Lymphocytic-Histiocytic Lymphoma,Mixed Lymphocytic-Histiocytic Lymphomas,Mixed Lymphoma,Mixed Lymphomas,Mixed-Cell Lymphomas,Non Hodgkin Lymphoma,Non Hodgkin's Lymphoma,Non-Cleaved-Cell Lymphoma, Small,Non-Hodgkins Lymphoma,Noncleaved-Cell Lymphoma, Small,Nonhodgkin's Lymphoma,Nonhodgkins Lymphoma,Pleomorphic Lymphoma,Pleomorphic Lymphomas,Reticulosarcomas,Reticulum Cell Sarcomas,Reticulum-Cell Sarcomas,Sarcoma, Reticulum Cell,Small Cleaved Cell Lymphoma, Diffuse,Small Non Cleaved Cell Lymphoma,Small Non-Cleaved-Cell Lymphomas,Small Noncleaved Cell Lymphoma,Small Noncleaved-Cell Lymphomas,Undifferentiated Lymphoma, Diffuse,Undifferentiated Lymphomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011030 Pneumothorax An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL. Pneumothorax, Primary Spontaneous,Pressure Pneumothorax,Primary Spontaneous Pneumothorax,Spontaneous Pneumothorax,Tension Pneumothorax,Pneumothorax, Pressure,Pneumothorax, Spontaneous,Pneumothorax, Tension,Spontaneous Pneumothorax, Primary
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D004868 Equipment Failure Failure of equipment to perform to standard. The failure may be due to defects or improper use. Defects, Equipment,Device Failure,Failure, Equipment,Malfunction, Equipment,Medical Device Failure,Misuse, Equipment,Device Failure, Medical,Device Failures, Medical,Failure, Medical Device,Failures, Medical Device,Defect, Equipment,Device Failures,Equipment Defect,Equipment Defects,Equipment Failures,Equipment Malfunction,Equipment Malfunctions,Equipment Misuse,Equipment Misuses,Failure, Device,Failures, Device,Failures, Equipment,Malfunctions, Equipment,Misuses, Equipment
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
Percutaneous placement of Hickman catheters for prolonged venous access.
December 1982, American journal of surgery,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
[The Hickman catheter as vascular access in bone marrow transplantation].
October 1996, Minerva cardioangiologica,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
The use of an implantable central venous (Hickman) catheter for long-term venous access in dogs undergoing bone marrow transplantation.
October 1992, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
[Central venous access in patients with Broviac- and Hickman catheters].
August 1985, Ugeskrift for laeger,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
Bone marrow transplantation through standard central venous catheters.
August 1995, Transplantation proceedings,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
December 1993, Gynecologic oncology,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
Triple lumen venous access for pediatric bone marrow transplantation candidates.
September 1987, Journal of surgical oncology,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters.
February 2001, Bone marrow transplantation,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
[The Hickman catheter in bone marrow transplantation, long-term cytostatic and infusion therapy. Experience of 102 catheters in children].
March 1987, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
T Kumagai, and H Sakamaki, and S Tanikawa, and H Akiyama, and Y Maeda, and T Sasaki, and S Tsuzuki, and S Takamoto, and K Takahashi, and Y Onozawa
Venous access using a Hickman catheter.
January 1983, Irish medical journal,
Copied contents to your clipboard!